Identification of a founder mutation in the <i>PRPH2</i> gene in an isolated Pacific Island population

PRPH2-associated inherited retinopathy demonstrated marked phenotypic variability in this cohort. Recognition of a founder genetic variant within a geographically isolated population highlights the importance of targeted molecular testing and may inform the development of tailored gene-based 20 therapeutic strategies.